First, the Chinese New Year's Eve dinner orders are full, and many well-known companies favor this market segment.
According to ** report, Chinese New Year's EveChinese New Year's Eve rice, as a "reunion banquet", is not only valued by every household, but also one of the vanes of the catering industry. Only one month before Chinese New Year's Eve, the reporter interviewed restaurants in Shanghai, Wuhan, Hangzhou and other places and found that the boxes of popular hotels in many places on Chinese New Year's Eve had already been booked. It doesn't matter if you can't book a dine-in meal, fresh food platforms, supermarkets, and catering stores have launched "pre-made Chinese New Year's Eve dinner" on offline platforms.
2. Domestic commercial aircraft enter the fast lane with policy and industry boost Alaska Airlines said in a statement on January 8 that preliminary reports from technicians show that some of its Boeing 737 Max 9 fleet have loose hardware. Previously, United Airlines found that bolts and other components were loose during an inspection of the Boeing 737 MAX 9, and many airlines around the world grounded the Boeing 737 MAX 9 aircraft for inspection.
3. Banxia Investment Li Bei: Avoiding the over-allotment of shares in the public offering body, it has increased its high dividends
This private equity manager is really hot. Nowadays, a sentence directly leaves the investors of the public offering ** speechless. At present, the main investment direction of the public offering is in liquor, medical care, semiconductors, artificial intelligence, and new energy.
Fourth, "Flowers" is popular, and many listed companies have attracted attention!
Hu Ge's TV series, I also watched it recently. To be honest, in the past, the main force of the a** field, when it was generally going to be harvested, would leave a little space for the market, and it would not be too ugly. And today's main force is really going to have no virtue, so A-shares are still adjusting.
5. The application for a new drug for Alzheimer's disease submitted by Eisai was approved in China
The Chinese trade name is Leyibao, and the indication is ** early Alzheimer's disease. China is the third country to approve the drug after the United States and Japan, indicating that the approval of new drugs is speeding up again. The news stimulated the pharmaceutical sector slightly.
The Shanghai Composite Index closed at 2,893 points yesterday, still not breaking through the 2,900-point integer mark. And yesterday was a shrinkage**, so it is not representative, the key depends on today's performance!
*After a continuous **, yesterday finally "soared" 02%, but ** is still relatively happy, because finally there is no need to lose money, but what would you think if you saw the Nikkei hit a 34-year high and U.S. stocks are on their way to new highs again?
Now the most important problem is that we have been losing money for three consecutive years, and we are on the way back to the beginning of this year, so we all feel more pessimistic, and even more pessimistic is that the long-term 5-year line and the 10-year line have begun to turn downward, and the 5-year line has not fallen below the 20-year line since its inception, and now it has fallen below, if this year's market can not appear first suppressed and then raised, or this year's annual line can not pull out a positive line, it indicates that A shares still have a long bear market time, are you willing to bet on this year's annual line closing positive line?